190 related articles for article (PubMed ID: 37566052)
21. Cotargeting Polo-Like Kinase 1 and the Wnt/β-Catenin Signaling Pathway in Castration-Resistant Prostate Cancer.
Li J; Karki A; Hodges KB; Ahmad N; Zoubeidi A; Strebhardt K; Ratliff TL; Konieczny SF; Liu X
Mol Cell Biol; 2015 Dec; 35(24):4185-98. PubMed ID: 26438599
[TBL] [Abstract][Full Text] [Related]
22. CUL4B: a novel epigenetic driver in Wnt/β-catenin-dependent hepatocarcinogenesis.
Mok MT; Cheng AS
J Pathol; 2015 May; 236(1):1-4. PubMed ID: 25664533
[TBL] [Abstract][Full Text] [Related]
23. Gossypol inhibits cullin neddylation by targeting SAG-CUL5 and RBX1-CUL1 complexes.
Yu Q; Hu Z; Shen Y; Jiang Y; Pan P; Hou T; Pan ZQ; Huang J; Sun Y
Neoplasia; 2020 Apr; 22(4):179-191. PubMed ID: 32145688
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of SCCRO (DCUN1D1) in prostate cancer and its proliferation-inhibiting effect on Lncap cells.
Zhang ZH; Li J; Luo F; Wang YS
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4283-4291. PubMed ID: 29077169
[TBL] [Abstract][Full Text] [Related]
25. Induction of LEF1 by MYC activates the WNT pathway and maintains cell proliferation.
Hao YH; Lafita-Navarro MC; Zacharias L; Borenstein-Auerbach N; Kim M; Barnes S; Kim J; Shay J; DeBerardinis RJ; Conacci-Sorrell M
Cell Commun Signal; 2019 Oct; 17(1):129. PubMed ID: 31623618
[TBL] [Abstract][Full Text] [Related]
26. The Yin-Yang of TCF/beta-catenin signaling.
Barker N; Morin PJ; Clevers H
Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
[TBL] [Abstract][Full Text] [Related]
27. CUL4B promotes aggressive phenotypes of HNSCC via the activation of the Wnt/β-catenin signaling pathway.
Wang Y; Yue D
Cancer Med; 2019 May; 8(5):2278-2287. PubMed ID: 30883036
[TBL] [Abstract][Full Text] [Related]
28. Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/β-Catenin Pathway.
Song X; Wang H; Wu J; Sun Y
Cancer Biother Radiopharm; 2020 Nov; 35(9):682-695. PubMed ID: 32407168
[No Abstract] [Full Text] [Related]
29. Neddylation is essential for β-catenin degradation in Wnt signaling pathway.
Wang B; Wang T; Zhu H; Yan R; Li X; Zhang C; Tao W; Ke X; Hao P; Qu Y
Cell Rep; 2022 Mar; 38(12):110538. PubMed ID: 35320710
[TBL] [Abstract][Full Text] [Related]
30. Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling.
Chen F; Chen X; Ren Y; Weng G; Keng PC; Chen Y; Lee SO
J Mol Med (Berl); 2019 Aug; 97(8):1169-1182. PubMed ID: 31187175
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-302 inhibits cell migration and invasion in cervical cancer by targeting DCUN1D1.
Jiang Y; Hou R; Li S; Li S; Dang G
Exp Ther Med; 2018 Aug; 16(2):1000-1008. PubMed ID: 30116351
[TBL] [Abstract][Full Text] [Related]
32. CBS9106-induced CRM1 degradation is mediated by cullin ring ligase activity and the neddylation pathway.
Saito N; Sakakibara K; Sato T; Friedman JM; Kufe DW; VonHoff DD; Kawabe T
Mol Cancer Ther; 2014 Dec; 13(12):3013-23. PubMed ID: 25253782
[TBL] [Abstract][Full Text] [Related]
33. MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway.
Wang D; Lu G; Shao Y; Xu D
Biomed Pharmacother; 2018 Mar; 99():334-339. PubMed ID: 29353209
[TBL] [Abstract][Full Text] [Related]
34. PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway.
Li Q; Ye L; Guo W; Wang M; Huang S; Peng X
J Exp Clin Cancer Res; 2017 Jun; 36(1):85. PubMed ID: 28645312
[TBL] [Abstract][Full Text] [Related]
35. Activation of the Wnt pathway through AR79, a GSK3β inhibitor, promotes prostate cancer growth in soft tissue and bone.
Jiang Y; Dai J; Zhang H; Sottnik JL; Keller JM; Escott KJ; Sanganee HJ; Yao Z; McCauley LK; Keller ET
Mol Cancer Res; 2013 Dec; 11(12):1597-610. PubMed ID: 24088787
[TBL] [Abstract][Full Text] [Related]
36. Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition of c-MYC transcription.
Antony L; van der Schoor F; Dalrymple SL; Isaacs JT
Prostate; 2014 Aug; 74(11):1118-31. PubMed ID: 24913829
[TBL] [Abstract][Full Text] [Related]
37. Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma.
Tan HY; Wang N; Li S; Hong M; Guo W; Man K; Cheng CS; Chen Z; Feng Y
Cell Physiol Biochem; 2018; 47(5):1819-1834. PubMed ID: 29953980
[TBL] [Abstract][Full Text] [Related]
38. New steps in the Wnt/beta-catenin signal transduction pathway.
Sakanaka C; Sun TQ; Williams LT
Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939
[TBL] [Abstract][Full Text] [Related]
39. Activated Wnt/β-Catenin signaling contributes to E3 ubiquitin ligase EDD-conferred docetaxel resistance in prostate cancer.
Bian P; Dou Z; Jia Z; Li W; Pan D
Life Sci; 2020 Aug; 254():116816. PubMed ID: 31472148
[TBL] [Abstract][Full Text] [Related]
40. Identification of a novel role of ZMIZ2 protein in regulating the activity of the Wnt/β-catenin signaling pathway.
Lee SH; Zhu C; Peng Y; Johnson DT; Lehmann L; Sun Z
J Biol Chem; 2013 Dec; 288(50):35913-24. PubMed ID: 24174533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
